Company news
Soleno Therapeutics, Inc. news in 2021
Soleno Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 9, 2021
Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
September 22, 2021
Soleno Therapeutics to Participate in the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 15, 2021
Soleno Therapeutics Announces Positive Data Showing Continued Significant Improvements in Symptoms of PWS following One Year Treatment with DCCR
September 7, 2021
Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a
June 1, 2021
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021
May 20, 2021
Soleno Therapeutics to Participate in the Oppenheimer Rare & Orphan Disease Summit
May 19, 2021
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 4, 2021
Soleno Therapeutics Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome
May 3, 2021
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall
April 13, 2021
Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference
March 8, 2021
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
March 2, 2021
Soleno Therapeutics Announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K(ATP) Channel Activators for the Treatment of Rare Diseases
February 22, 2021
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
February 4, 2021
Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
January 27, 2021
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
January 3, 2021